New, groundbreaking technology may lead to a new generation of healthy dairy products

Chr. Hansen’s scientists see interesting potential in new, unique fermentation technology which improves conditions for “friendly” gut bacteria.

Yoghurts, soft drinks or juices with many more of the “friendly” gut bacteria (probiotics) with higher longevity and improved health effects – superior fermented dairy products or new developments within functional foods, we can’t even imagine today. These are some of the interesting prospects, Chr. Hansen researchers and technicians are facing with the help from this new technology.

The agreement with Chr. Hansen, a leading manufacturer of food ingredients, demonstrates commercial viability of Jurag Separations unique separation system and confirms the technology’s attractiveness for scalable and productive solutions in industrial settings.

With the joint venture Chr. Hansen gets access to Jurag Separations patented REED filtration technology, which offers advanced electro-membrane solutions for separation of ionic species directly from fermentation broth as well as from a variety of other complex process streams.

Zymenex has initiated the Phase II part of the clinical trial in seriously ill children with MLD.

Zymenex has initiated the Phase II part of the clinical trial in seriously ill children with MLD.

The trial will hopefully show the way to a cure for the rare and until now incurable disease, Metachromatic Leukodystrophy (MLD), which is diagnosed in children between the ages of 2-5 years and paralyses the nervous system in such a way that the children die.

Santaris Pharma presents positive clinical data on SPC2996 in Chronic Lymphocytic Leukaemia.

Santaris Pharma, the Danish biopharmaceutical company, announced today that SPC2996, the Company’s new RNA Antagonist of Bcl-2, has shown early evidence of efficacy in an initial Phase I/II clinical study in Chronic Lymphocytic Leukaemia (CLL). The results of the study were reported this week at the 2007 Annual Meeting of the American Society of Clinical Oncology, held in Chicago, Illinois.